Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of ...
DUBLIN, Oct. 25, 2023 /PRNewswire/ -- The "Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of ...
Aspergillosis is a disease caused by a filamentous fungi, Aspergillus. The mold is present practically everywhere including trees, grain crops, and soil (outdoors); bedding mattresses, cushions, and ...
Through long-standing research supported by the National Institutes of Health, investigators at Johns Hopkins Medicine have ...
SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic aspergillosis treatment market is estimated to be valued at US$ 2,916.3 million in 2021 and is ...
BUENOS AIRES, Argentina — There is little doubt about the importance of starting antifungal treatment promptly for invasive pulmonary aspergillosis when the clinical condition suggests it in high risk ...
Report Ocean has published a new report on the Aspergillosis Treatment Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers ...
With surging antifungal resistance and a rise in severe infections following the COVID-19 pandemic, aspergillosis has re-emerged as a critical threat to vulnerable patients worldwide, underscoring the ...
San Jose, CA, March 18, 2017 --(PR.com)-- Credence Research has recently issued a new market assessment report titled “Aspergillosis Treatment – Growth, Future Prospects and Competitive Analysis, 2016 ...
The first FDA-cleared urine-based test for invasive aspergillosis has been validated. The rapid assay accurately detects ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results